Testing the Feasibility and Acceptability of Social Media and Digital Therapeutics to Decrease Vaping Behaviors
NCT ID: NCT05994209
Last Updated: 2025-07-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
PHASE1
189 participants
INTERVENTIONAL
2025-06-04
2026-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Smartphone Application (ACT on Vaping) for Vaping Cessation in Young Adults
NCT05897242
Goal2QuitVaping for Nicotine Vaping Cessation Among Adolescents
NCT04951193
A Digital Intervention (ACT on Vaping App) for Vaping Cessation in Young Adult E-Cigarette Users
NCT06909500
Text Message Quit Vaping Intervention for Adolescents
NCT04919590
Impact of E-Cigarette Prevention Messages on Adolescents
NCT05985538
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control Group
Nationwide resource referral and intervention waitlist
No interventions assigned to this group
Experimental Group A: Mobile App Intervention
quitSTART Mobile Application Adapted for Vaping Cessation Among Young Adults
quitSTART Mobile Application
Mobile application with educational content, motivational messages, self-monitoring, and tips for managing cravings to support vaping cessation among young adults.
Experimental Group B: Mobile App Intervention with Embedded Chatbot Feature
quitSTART Mobile Application Adapted for Vaping Cessation Among Young Adults Including Embedded Chatbot Feature
quitSTART Mobile Application
Mobile application with educational content, motivational messages, self-monitoring, and tips for managing cravings to support vaping cessation among young adults.
Chatbot Feature in quitSTART Mobile Application
In-App chatbot feature emedded into quitSTART mobile application to motivate vaping cessation and support app navigation.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
quitSTART Mobile Application
Mobile application with educational content, motivational messages, self-monitoring, and tips for managing cravings to support vaping cessation among young adults.
Chatbot Feature in quitSTART Mobile Application
In-App chatbot feature emedded into quitSTART mobile application to motivate vaping cessation and support app navigation.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* English Speaking
* Have daily access to a smartphone
* Current vaping product user (P30D)
* Identified as socially networking about a desire to quit vaping and/or experiencing negative health outcomes due to vaping
* Vaping product user only (i.e., not using vaping as a means to support combustible smoking cessation)
15 Years
25 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The University of Texas Health Science Center, Houston
OTHER
University of South Carolina
OTHER
National Institute on Drug Abuse (NIDA)
NIH
Washington University School of Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Washington University in St. Louis, School of Medicine
St Louis, Missouri, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.